Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma.
about
A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas.Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patients.GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients.Gemcitabine, dexamethasone, and cisplatin (GDP) as salvage chemotherapy for patients with relapsed or refractory peripheral T cell lymphoma-not otherwise specified.Concurrent IMRT and weekly cisplatin followed by GDP chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell lymphomaComparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomas.Efficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphoma.Interactions Between Inflammatory Bowel Disease Drugs and Chemotherapy.Intensity-modulated radiation therapy followed by GDP chemotherapy for newly diagnosed stage I/II extranodal natural killer/T cell lymphoma, nasal type.CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin.The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkers.Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients.A pilot study of the safety and efficacy of dexamethasone, ifosfamide, methotrexate and gemcitabine chemotherapy for natural killer/T-cell lymphoma.CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial.
P2860
Q33409608-641AEAAD-0DD9-4EF4-99FD-C88FD79C3CEFQ33415901-F84C060D-4D0D-4934-A22A-9FF8C42017FAQ33429990-E401DF3B-BADF-454D-BDE0-4DE61474EDB1Q33431457-775F0732-AF65-4827-B750-10F50DD35537Q33436867-EF86DF1C-BAC9-444D-B811-867B8793C6B4Q35044989-38E7D1D3-E4E9-455F-B6F0-AA458E306AA2Q35989647-7AA0EB17-1C6B-42C5-9028-E38413C17F53Q37301747-CF46121E-4795-439C-A8A0-CCC9468BF7A8Q38973323-18859C9A-38E9-41CD-8CF1-0B545C5D5008Q40128026-74D4C4C8-1A8B-4998-B83A-3E684C323607Q41246604-8EB8BF43-CC8C-46B3-9AC6-49F40BB6B149Q48301800-8BAFAFF5-35BF-429C-9D55-E6A0CD158E68Q51161466-4B0B484D-F5F0-44AD-9B90-CDCE9A88D778Q53651860-D86E182A-54DD-4EEF-A4CB-49DB81AAAC25Q53828417-E5A06F80-8DC2-4EA4-97A8-792DAA3C7540
P2860
Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma.
@ast
Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma.
@en
type
label
Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma.
@ast
Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma.
@en
prefLabel
Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma.
@ast
Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma.
@en
P2093
P2860
P1433
P1476
Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma.
@en
P2093
Chang-Gong Zhang
Jian-Liang Yang
Li-Qiang Zhou
Sheng Yang
Sheng-Yu Zhou
Xiao-Hui He
P2860
P2888
P356
10.1007/S12032-012-0351-4
P577
2012-12-27T00:00:00Z
P6179
1017674867